Literature DB >> 1590792

Characterization of proteoglycans in Alzheimer's disease fibroblasts.

M Zebrower1, C Beeber, F J Kieras.   

Abstract

Skin fibroblasts lines established from patients with Alzheimer's disease and old normal individuals were cultured with 35S-sodium sulfate and 3H-glucosamine. Proteoglycans were isolated and characterized. Sulfate incorporation into proteoglycans increased in Alzheimer's disease fibroblasts relative to normal controls. These increases changed the ratio of chondroitin sulfate to heparan sulfate proteoglycan from 1.4 to 1.7 (p = 0.0012) and decreased the ratio of cell to medium proteoglycans from 0.32 to 0.26 in normal and Alzheimer fibroblasts (p = 0.006), respectively. HPLC analysis of the disaccharides produced by chondroitinase ABC revealed no differences in composition between proteoglycans of Alzheimer and normal fibroblasts in either the cell or medium fraction. However, analysis of disaccharides produced by heparinase plus heparitinase showed differences in composition in the medium but not the cell fraction. delta UA-GlcNS was increased by 30% while delta UA-GlcNS-6S was reduced by 40% in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1590792     DOI: 10.1016/s0006-291x(05)80023-3

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

Review 1.  Proteoglycans and the acute-phase response in Alzheimer's disease brain.

Authors:  B Leveugle; H Fillit
Journal:  Mol Neurobiol       Date:  1994 Aug-Dec       Impact factor: 5.590

2.  Significantly reduced expression of the proteoglycan decorin in Alzheimer's disease fibroblasts.

Authors:  E Brandan; F Melo; M García; M Contreras
Journal:  Clin Mol Pathol       Date:  1996-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.